NY-ESO-1 Protein Vaccine Combining Alum, CpG ODN, and HH2 Complex Adjuvant Induces Protective and Therapeutic Anti-Tumor Responses in Murine Multiple Myeloma

BACKGROUND: NY-ESO-1 is an ideal target for multiple myeloma immunotherapy. Alum, CpG ODN and HH2 complex is a safe and effective adjuvant for cancer vaccine. METHODS: We constructed NY-ESO-1 protein vaccine combined with alum, CpG ODN, and HH2 complex adjuvant to immunize the BALB/c mice inoculated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Huang, Wei, Gao, Hua, Liu, Ting Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431605/
https://www.ncbi.nlm.nih.gov/pubmed/32884292
http://dx.doi.org/10.2147/OTT.S255713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431605/
https://www.ncbi.nlm.nih.gov/pubmed/32884292
http://dx.doi.org/10.2147/OTT.S255713

Ejemplares similares